Salarius Pharmaceuticals IncEigentümerstruktur
| Preis (2026-01-09) | 52W Hoch | 52W Tief |
| 0.8198000000000001 USD | 14,994 USD | 0,515 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 26 USD | 0 | 0 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 5.862.178 | 3,15 | 0,31 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Salarius Pharmaceuticals Inc
Mitarbeiter 2
Handelsplatz NASDAQ
Ticker Symbol SLRX
IPO Datum 2015-01-29
Adresse 2450 Holcombe Blvd., Houston, TX, United States, 77021
Webseite https://www.salariuspharma.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Mark J. Rosenblum CPA | Executive VP & CFO |
| 2 | Mr. Frederick E. Pierce II | CEO & Director |
| 3 | Dr. Barbara Hibner Ph.D. | Chief Scientific Officer & Director |
| 4 | Dr. Nadeem Q. Mirza M.D., M.P.H. | Senior Vice President of Clinical Development |
| 5 | Mr. Peter K. Marschel M.B.A., M.S. | Chief Business Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | HRT FINANCIAL LLC | 0,00% | 0,00 Mio. USD |
| 2 | UBS Group AG | 0,00% | 0,00 Mio. USD |
| 3 | Cubist Systematic Strategies, LLC | 0,00% | 0,00 Mio. USD |
| 4 | Goldman Sachs Group Inc | 0,00% | 0,00 Mio. USD |
| 5 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 6 | Barclays PLC | 0,00% | 0,00 Mio. USD |
| 7 | Citigroup Inc | 0,00% | 0,00 Mio. USD |
| 8 | Tower Research Capital LLC | 0,00% | 0,00 Mio. USD |
| 9 | Advisor Group Holdings, Inc. | 0,00% | 0,00 Mio. USD |
| 10 | Mount Yale Investment Advisors, LLC | 0,00% | 0,00 Mio. USD |
| 11 | Bank of America Corp | 0,00% | 0,00 Mio. USD |
| 12 | Morgan Stanley - Brokerage Accounts | 0,00% | 0,00 Mio. USD |
| 13 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 14 | SBI Securities Co Ltd | 0,00% | 0,00 Mio. USD |
| 15 | Mascagni Wealth Management, Inc. | 0,00% | 0,00 Mio. USD |
| 16 | TWO SIGMA SECURITIES, LLC | 0,00% | 0,00 Mio. USD |